PRVL - Prevail Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $2.72. This is a potential upside of $2.72 (0%) from yesterday's end of day stock price of $0.

Prevail Therapeutics's activity chart (see below) currently has 8 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80% with an average time for these price targets to be met of 173.33 days.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 23-Dec-2020. First documented stock forecast 15-Jul-2019.

Best performing analysts who are covering PRVL - Prevail Therapeutics:

Laura Chico Christopher Raymond Paul Matteis

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

22

$-1 (-4.35%)

22

3 years 3 months 5 days ago

2/5 (40%)

$-1.18 (-5.09%)

234

Buy

23

23

3 years 3 months 11 days ago

2/2 (100%)

$3.81 (25.20%)

83

Sell

20

$-3 (-13.04%)

3 years 7 months 17 days ago

3/3 (100%)

$5.53 (38.90%)

203

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRVL (Prevail Therapeutics) average time for price targets to be met?

On average it took 173.33 days on average for the stock forecasts to be realized with a an average price target met ratio 80

Which analyst has the current highest performing score on PRVL (Prevail Therapeutics) with a proven track record?

LAURA CHICO

Which analyst has the current lower performing score on PRVL (Prevail Therapeutics) with a proven track record?

PAUL MATTEIS

Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?

Laura Chico works at WEDBUSH and has 18 price targets and 10 ratings on PRVL

Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?

Paul Matteis with highest potential upside - $0

Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?

Christopher Raymond with lowest potential downside - -$3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?